Posted By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Diabetic recipe
Attributed to Delicious Dish for diabetics by Robin Ellis, Published by Skyhorse Publishing Inc. New York. You can view its website atwww.skyhorsepublishing.com.
This is adapted from Rena Salaman's lovely and authentic Greek food. It's a refreshing garlicky sauce that goes particularly well with grilled summer vegetables, chicken and lambs.
500 ml/18 oz./2cups low-fat organic yogurt - wrapped in muslin and squeezed gently to drain it a little or left overnight in a sieve to grain in a bowl
2 tbsp. olive oil
2 tsp. white wine or cider vinegar
2 cloves of garlic - pulped in a mortar with a little salt
2 fresh mint leaves - finely chopped
1/4 medium cucumber - peeled, quartered length wise, deseeded and finely chopped
salt and pepper
1. Carefully scrape the drained yogurt into a mixing bowl
2. In a separate small bowl, whisk the oil and the vinegar together. Mix in the garlic and mint.
3. Fold this into the yogurt, then add the cucumber. Season lightly, taste and refrigerate.
Weight Loss the Easy Ways
Andrea Albright Featured on Health and Fitness Jan. 2015
will Personally Coach You How to Get There The Easy Way
Wednesday, 24 June 2015
Tuesday, 23 June 2015
The Holistic prevention, management and treatment of Polycystic Ovarian Syndrome: TCM Herbal Medicine for Kidney Yin deficiency - Huang Lian
By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cancer(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women. Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).
In Traditional Chinese Medicine Perspective
While conventional medicine focus of using synthetic medication to induce ovulation and assisted artificial insemination for infertility couple, if the medicine fail, traditional Chinese medicine views polycystic ovarian syndrome in different approaches. Polycystic ovary syndrome, according to traditional Chinese medicine is a medical condition characterized by accumulative of fluid over a prolonged period of time causes of dampness and phlegms(1247a)(1247b) build up on the ovaries due to the effects of vary differentiations, affecting not only the women’s menstrual cycle, but also ovulation and fertility(1247a)(1247b).
PCOs Treatment according traditional Chinese medicine
Depending to differentiation, most common diagnosis of polycystic ovary syndrome can be classified into
Kidney yin deficiency
Along with common symptoms mentioned above, women with PCOs diagnosed with kidney yin deficiency may also experience yin vacuity induced cold expressive syndrome, including soreness of waist and knees(1848), lassitude(1848) and fatigue(1848), short breath(1848), poor appetite(1848), aversion to cold(184), cold extremities(1848), ringing in the ears(1850), migraine(1849), hearing problems(1850), a dry mouth and throat(1851), pale fingernails(1851), tidal fever(1851)and night sweating(1851), soles(1851) and chest(1851), constipation(1852),,......... as the kidneys no longer perform their functions of regulating fluid in moistening and nourishing organs and tissues of the body. According to TCM, too much cold/raw foods can aggravate the condition.
In the review of the Data base provided by PubMed, kidney yin deficiency may induce functional impairment or metabolic derangements in vital organs/tissues(1853) persuaded a conglomeration of sundry chronic disease state(1853), cognitive dysfunction(1854), vasomotor symptoms(1855),..... leading to accumulation of fluid in the body organ, promoted accentuation of inflammatory development of phlegm.
Kidney yin deficiency has shown to alter amino acid metabolism(1856), energy metabolism(1856) and gut microflora(1856), anovulatory infertility(1857) and
hypertension(1858), hyperinsulinemia(1859) and hyperandrogenia(1859)..... of which related to symptoms of PCOs(1859).
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(1246) [Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet]. [Article in Chinese] by Feng Y, Gao YP.(PubMed)
(1247) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan, J.(PubMed)
(1247a) A Comprehensive Treatment of Polycystic Ovarian Syndrome (PCOS) by Liqin Zhao(1848) ontrolled trail on moxibustion for maintenance hemodialysis patients in deficiency syndrome]. [Article in Chinese] Li N1, Qiu MY, Hao JR, Zhang QM, Wang SH, Liang F, Yin Y, Luan J, Ge GZ, Qin T, Li BQ.(PubMed)
(1848) ontrolled trail on moxibustion for maintenance hemodialysis patients in deficiency syndrome]. [Article in Chinese] Li N1, Qiu MY, Hao JR, Zhang QM, Wang SH, Liang F, Yin Y, Luan J, Ge GZ, Qin T, Li BQ.(PubMed)
(1849) [Observation on therapeutic effect of the new Bianshi (stone needle) therapy on migraine]. [Article in Chinese] Yin ZJ1, Yan YJ, Bao HL(PubMed)
(1850) [Study on relation of kidney-deficiency with hearing damage and serum trace elements in patients with chronic nephropathy]. [Article in Chinese] by Yu J1, Xu Y, Fu XD.(PubMed)
(1851) [A family survey of syndromes of traditional Chinese medicine in patients with beta-thalassemia]. [Article in Chinese] by Wang WJ1, Wu ZK, Zhang XH, Liu WJ, Liu YM, Fang SP, Wang RX, Zhang C, Li PP, Luo RG.(PubMed)
(1852) The clinical experiences of Dr. CAI Gan in treating chronic constipation by Zhang ZL1, Zhu MP, Liu Q, Lei YX.(PubMed)
(1853) [Analysis of 35 cases of pathology in yin deficiency syndrome]. [Article in Chinese] by Dai HL, Chen ZL, Song QL.(PubMed)
(1854) Liuwei Dihuang decoction facilitates the induction of long-term potentiation (LTP) in senescence accelerated mouse/prone 8 (SAMP8) hippocampal slices by inhibiting voltage-dependent calcium channels (VDCCs) and promoting N-methyl-d-aspartate receptor (NMDA) receptors by Huang Y1, Zhang H, Yang S, Qiao H, Zhou W, Zhang Y.(PubMed)
(1855) Diagnosis of symptomatic postmenopausal women by traditional Chinese medicine practitioners by Zell B1, Hirata J, Marcus A, Ettinger B, Pressman A, Ettinger KM.(PubMed)
(1856) An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China by Jiang N1, Liu HF2, Li SD1, Zhou WX1, Zhang YX1, Zhang Q3, Yan XZ3.(PubMed)
(1857) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan J.(PubMed)
(1858) Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients by Wang J1, Xiong X1, Liu W1.(PubMed)
(1859) [Clinical observation on treatment of hyperinsulinemia and hyperandrogenism anovulatory patient with replenishing kidney-yin drugs]. [Article in Chinese] by Zhou LR1, Yu J.(PubMed)
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cancer(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women. Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).
In Traditional Chinese Medicine Perspective
While conventional medicine focus of using synthetic medication to induce ovulation and assisted artificial insemination for infertility couple, if the medicine fail, traditional Chinese medicine views polycystic ovarian syndrome in different approaches. Polycystic ovary syndrome, according to traditional Chinese medicine is a medical condition characterized by accumulative of fluid over a prolonged period of time causes of dampness and phlegms(1247a)(1247b) build up on the ovaries due to the effects of vary differentiations, affecting not only the women’s menstrual cycle, but also ovulation and fertility(1247a)(1247b).
PCOs Treatment according traditional Chinese medicine
Depending to differentiation, most common diagnosis of polycystic ovary syndrome can be classified into
Kidney yin deficiency
Along with common symptoms mentioned above, women with PCOs diagnosed with kidney yin deficiency may also experience yin vacuity induced cold expressive syndrome, including soreness of waist and knees(1848), lassitude(1848) and fatigue(1848), short breath(1848), poor appetite(1848), aversion to cold(184), cold extremities(1848), ringing in the ears(1850), migraine(1849), hearing problems(1850), a dry mouth and throat(1851), pale fingernails(1851), tidal fever(1851)and night sweating(1851), soles(1851) and chest(1851), constipation(1852),,......... as the kidneys no longer perform their functions of regulating fluid in moistening and nourishing organs and tissues of the body. According to TCM, too much cold/raw foods can aggravate the condition.
In the review of the Data base provided by PubMed, kidney yin deficiency may induce functional impairment or metabolic derangements in vital organs/tissues(1853) persuaded a conglomeration of sundry chronic disease state(1853), cognitive dysfunction(1854), vasomotor symptoms(1855),..... leading to accumulation of fluid in the body organ, promoted accentuation of inflammatory development of phlegm.
Kidney yin deficiency has shown to alter amino acid metabolism(1856), energy metabolism(1856) and gut microflora(1856), anovulatory infertility(1857) and
hypertension(1858), hyperinsulinemia(1859) and hyperandrogenia(1859)..... of which related to symptoms of PCOs(1859).
6. Huang lian
Chemical Constutuents(2043)
1. Berberine
2. Colchicine
3. Coptisine
4. Worenine
5. Palmatine
6. Jatrorrhizine
7. Magnoflorine
8. Kutkin
9. Etc.
Berberine and chemical compound found in huang lian and the whole itself have shown a positive effect in reduced risk of diabetes(2041)(2042) and cardiovascular disease(2057)(2039)(2040)(2058) in women with kidney yin deficiency induced PCOs due to their glucose and lipid metabolism responds(2061) on metabolic syndrome(2064)(2069), including glucose level(2061)(2062), insulin resistance(2059)(2060)(2062), hypertensive(2065)(2066), hyperglycaemia[total cholesterol, triglyceride levels, urinary protein excretion, serum creatinine (Scr) and blood urea nitrogen (BUN)](2062)(2063)(2064) anti hyperglycaemic(2042)(2064), obesity(2064)(2067)(2068),.......via immunomodulatory(2070)(2071), antioxidant(2041)(2047)(2048)and anti-inflammatory activities.
Unfotunately, according Shanghai University of Traditional Chinese Medicine, increasing the systemic exposure of Rhizoma coptidis alkaloids(2071) and over doses of all alkaloids, especially berberine(2072) may induce risk of the acute toxicity.
Hu huang Lian or Huang Lian is also known as coptis rhizome. The bitter and cool herb has been used in TCM as anti palette coagulation(2037)(2038), anti arrhythmia(2039)(2040), anti heart failure(2039), anti diabetic(2041)(2042), anti cancer(2044)(2045)(2046), anti inflammatory(2049)(2050) and antioxidant(2048)(2047) advocate and to relief heat toxicity(2051)(2052), indigestion(2053), inflammation of small intestine(2053), diarrhea(2054)(2055), fever(2054), jaundice(2054), insomnia(2056) and relieve pain(2055),,,,,,,,,, as it eliminates empty-Heat and Damp-Heat, clears Heat, etc., by enhancing the functions of heart, large intestine, liver, and stomach channels(2043)
Chemical Constutuents(2043)
1. Berberine
2. Colchicine
3. Coptisine
4. Worenine
5. Palmatine
6. Jatrorrhizine
7. Magnoflorine
8. Kutkin
9. Etc.
Berberine and chemical compound found in huang lian and the whole itself have shown a positive effect in reduced risk of diabetes(2041)(2042) and cardiovascular disease(2057)(2039)(2040)(2058) in women with kidney yin deficiency induced PCOs due to their glucose and lipid metabolism responds(2061) on metabolic syndrome(2064)(2069), including glucose level(2061)(2062), insulin resistance(2059)(2060)(2062), hypertensive(2065)(2066), hyperglycaemia[total cholesterol, triglyceride levels, urinary protein excretion, serum creatinine (Scr) and blood urea nitrogen (BUN)](2062)(2063)(2064) anti hyperglycaemic(2042)(2064), obesity(2064)(2067)(2068),.......via immunomodulatory(2070)(2071), antioxidant(2041)(2047)(2048)and anti-inflammatory activities.
Unfotunately, according Shanghai University of Traditional Chinese Medicine, increasing the systemic exposure of Rhizoma coptidis alkaloids(2071) and over doses of all alkaloids, especially berberine(2072) may induce risk of the acute toxicity.
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(1246) [Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet]. [Article in Chinese] by Feng Y, Gao YP.(PubMed)
(1247) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan, J.(PubMed)
(1247a) A Comprehensive Treatment of Polycystic Ovarian Syndrome (PCOS) by Liqin Zhao(1848) ontrolled trail on moxibustion for maintenance hemodialysis patients in deficiency syndrome]. [Article in Chinese] Li N1, Qiu MY, Hao JR, Zhang QM, Wang SH, Liang F, Yin Y, Luan J, Ge GZ, Qin T, Li BQ.(PubMed)
(1849) [Observation on therapeutic effect of the new Bianshi (stone needle) therapy on migraine]. [Article in Chinese] Yin ZJ1, Yan YJ, Bao HL(PubMed)
(1850) [Study on relation of kidney-deficiency with hearing damage and serum trace elements in patients with chronic nephropathy]. [Article in Chinese] by Yu J1, Xu Y, Fu XD.(PubMed)
(1851) [A family survey of syndromes of traditional Chinese medicine in patients with beta-thalassemia]. [Article in Chinese] by Wang WJ1, Wu ZK, Zhang XH, Liu WJ, Liu YM, Fang SP, Wang RX, Zhang C, Li PP, Luo RG.(PubMed)
(1852) The clinical experiences of Dr. CAI Gan in treating chronic constipation by Zhang ZL1, Zhu MP, Liu Q, Lei YX.(PubMed)
(1853) [Analysis of 35 cases of pathology in yin deficiency syndrome]. [Article in Chinese] by Dai HL, Chen ZL, Song QL.(PubMed)
(1854) Liuwei Dihuang decoction facilitates the induction of long-term potentiation (LTP) in senescence accelerated mouse/prone 8 (SAMP8) hippocampal slices by inhibiting voltage-dependent calcium channels (VDCCs) and promoting N-methyl-d-aspartate receptor (NMDA) receptors by Huang Y1, Zhang H, Yang S, Qiao H, Zhou W, Zhang Y.(PubMed)
(1855) Diagnosis of symptomatic postmenopausal women by traditional Chinese medicine practitioners by Zell B1, Hirata J, Marcus A, Ettinger B, Pressman A, Ettinger KM.(PubMed)
(1856) An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China by Jiang N1, Liu HF2, Li SD1, Zhou WX1, Zhang YX1, Zhang Q3, Yan XZ3.(PubMed)
(1857) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan J.(PubMed)
(1858) Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients by Wang J1, Xiong X1, Liu W1.(PubMed)
(1859) [Clinical observation on treatment of hyperinsulinemia and hyperandrogenism anovulatory patient with replenishing kidney-yin drugs]. [Article in Chinese] by Zhou LR1, Yu J.(PubMed)
(2037) Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells by Gao MY1, Chen L1, Yang L1, Yu X1, Kou JP2, Yu BY3.(PubMed)
(2038) Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells by Holy EW1, Akhmedov A, Lüscher TF, Tanner FC.(PubMed)
(2039) Cardiovascular actions of berberine by Lau CW1, Yao XQ, Chen ZY, Ko WH, Huang Y.(PubMed)
(2040) Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model by Wang LH1, Yu CH, Fu Y, Li Q, Sun YQ.(PubMed)
(2041)Application of berberine on treating type 2 diabetes mellitus by Pang B1, Zhao LH2, Zhou Q3, Zhao TY1, Wang H1, Gu CJ1, Tong XL1.(PubMed)
(2042) Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms by Ni WJ1, Ding HH2, Tang LQ3.(PubMed)
(2043) Huang lian(Complementary and Alternative Healing University)
(2044) Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines by Iizuka N1, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T, Hazama S, Oka M.(PubMed)
(2045) Suppression of human breast cancer cell metastasis by coptisine in vitro by Li J1, Qiu DM, Chen SH, Cao SP, Xia XL.(PubMed)
(2046) Berberine hydrochloride impact on physiological processes and modulation of twist levels in nasopharyngeal carcinoma CNE-1 cells by Li CH1, Wu DF, Ding H, Zhao Y, Zhou KY, Xu DF.(PubMed)
(2047) Analysis of the antioxidative function of the radioprotective Japanese traditional (Kampo) medicine, hangeshashinto, in an aqueous phase by Matsumoto C1, Sekine-Suzuki E2, Nyui M3, Ueno M3, Nakanishi I3, Omiya Y4, Fukutake M1, Kase Y4, Matsumoto KI5.(PubMed)
(2048) Characterization, antibacterial, antioxidant, and cytotoxic activities of ZnO nanoparticles using Coptidis Rhizoma by Nagajyothi PC1, Sreekanth TV2, Tettey CO1, Jun YI1, Mook SH3.(PubMed)
(2049) Coptisine attenuates obesity-related inflammation through LPS/TLR-4-mediated signaling pathway in Syrian golden hamsters by Zou ZY1, Hu YR1, Ma H1, Wang YZ1, He K1, Xia S1, Wu H2, Xue DF2, Li XG3, Ye XL4.(PubMed)
(2050) [Progress of berberine for treatment of type 2 diabetes]. [Article in Chinese] by Deng XW, Xie N.(PubMed)
(2051) Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations by Tang J1, Feng Y, Tsao S, Wang N, Curtain R, Wang Y.(PubMed)
(2052) Safety evaluation of main alkaloids from Rhizoma Coptidis by Yi J1, Ye X, Wang D, He K, Yang Y, Liu X, Li X.(PubMed)
(2053) Effects of San-Huang-Xie-Xin-tang, a traditional Chinese prescription for clearing away heat and toxin, on the pacemaker activities of interstitial cells of Cajal from the murine small intestine by Kim BJ1, Kim H2, Lee GS3, So I4, Kim SJ5.(PubMed)
(2054) Study of the anti-MRSA activity of Rhizoma coptidis by chemical fingerprinting and broth microdilution methods by Luo JY1, Yan D2, Yang MH3.(PubMed)
(2055) Analgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndrome by Tjong Y1, Ip S, Lao L, Fong HH, Sung JJ, Berman B, Che C.(PubMed)
(2056) Integrated pharmacokinetics of five protoberberine-type alkaloids in normal and insomnic rats after single and multiple oral administration of Jiao-Tai-Wan by He W1, Liu G1, Cai H1, Sun X1, Hou W1, Zhang P2, Xie Z3, Liao Q4.(PubMed)
(2057) Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and AMPK-dependent lipid lowering effect in hepatocytes. Ho FM1, Liao YH, Yang AJ, Lee Chao PD, Hou YC, Huang CT, Lin SR, Lee KR, Huang KC, Lin WW.(PubMed)
(2058) Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats by Gong LL1, Fang LH, Wang SB, Sun JL, Qin HL, Li XX, Wang SB, Du GH.(PubMed)
(2059) Effect of Coptidis Rhizoma extracts in a water-based solution on insulin resistance in 3T3-L1 adipocytes by Yuan Y1, Wang X, Lu X, Marunaka Y, Wang X.(PubMed)
(2060) Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double-blind randomised controlled trial by Li Y1, Kuang H, Shen W, Ma H, Zhang Y, Stener-Victorin E, Hung E, Ng Y, Liu J, Kuang H, Hou L, Wu X.(PubMed)
(2061) Gut microbes and Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice by Xie W1, Gu D, Li J, Cui K, Zhang Y.(PubMed)
(2062) Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin by Wu D1, Wen W, Qi CL, Zhao RX, Lü JH, Zhong CY, Chen YY.(PubMed)
(2063) Jiao tai wan attenuates hepatic lipid accumulation in type 2 diabetes mellitus by Huang Z1, Xu X, Lu F, Wang N, Chen G, Zhao Y, Zou X, Wang K, Dong H, Xu L.(PubMed)
(2064) Traditional chinese medicine in treatment of metabolic syndrome by Yin J1, Zhang H, Ye J. (PubMed)
(2065) Simultaneous determination of ten alkaloids of crude and wine-processed Rhizoma Coptidis aqueous extracts in rat plasma by UHPLC-ESI-MS/MS and its application to a comparative pharmacokinetic study by Qian XC1, Zhang L2, Tao Y3, Huang P1, Li JS4, Chai C3, Li W5, Di LQ1, Cai BC3.(PubMed)
(2066) Effects of San-Huang-Xie-Xin-Tang on U46619-induced increase in pulmonary arterial blood pressure by Tsai HH1, Chen IJ, Lo YC.(PubMed)
(2067) Coptis chinensis alkaloids exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating C/EBP-α and PPAR-γ by Choi JS1, Kim JH2, Ali MY1, Min BS3, Kim GD4, Jung HA5.(PubMed)
(2068) [Pharmacodyamic material basis of rhizoma coptidis on insulin resistance]. [Article in Chinese] by Li J1, Meng X, Fan X, Lai X, Zhang Y, Zeng Y.(PubMed)
(2069) Inhibition of preadipocyte differentiation and lipid accumulation by Orengedokuto treatment of 3T3-L1 cultures. Ikarashi N1, Tajima M, Suzuki K, Toda T, Ito K, Ochiai W, Sugiyama K.(PubMed)
(2070) Potential ex vivo immunomodulatory effects of San-Huang-Xie-Xin-Tang and its component herbs on mice and humans by Li CY1, Hou YC, Lee Chao PD, Shia CS, Hsu IC, Fang SH.(PubMed)
(2071) Lipopolysaccharide increased the acute toxicity of the Rhizoma coptidis extract in mice by increasing the systemic exposure to Rhizoma coptidis alkaloids by Ma BL1, Ma YM, Gao CL, Wu JS, Qiu FR, Wang CH, Wang XH.(PubMed)
(2038) Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells by Holy EW1, Akhmedov A, Lüscher TF, Tanner FC.(PubMed)
(2039) Cardiovascular actions of berberine by Lau CW1, Yao XQ, Chen ZY, Ko WH, Huang Y.(PubMed)
(2040) Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model by Wang LH1, Yu CH, Fu Y, Li Q, Sun YQ.(PubMed)
(2041)Application of berberine on treating type 2 diabetes mellitus by Pang B1, Zhao LH2, Zhou Q3, Zhao TY1, Wang H1, Gu CJ1, Tong XL1.(PubMed)
(2042) Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms by Ni WJ1, Ding HH2, Tang LQ3.(PubMed)
(2043) Huang lian(Complementary and Alternative Healing University)
(2044) Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines by Iizuka N1, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T, Hazama S, Oka M.(PubMed)
(2045) Suppression of human breast cancer cell metastasis by coptisine in vitro by Li J1, Qiu DM, Chen SH, Cao SP, Xia XL.(PubMed)
(2046) Berberine hydrochloride impact on physiological processes and modulation of twist levels in nasopharyngeal carcinoma CNE-1 cells by Li CH1, Wu DF, Ding H, Zhao Y, Zhou KY, Xu DF.(PubMed)
(2047) Analysis of the antioxidative function of the radioprotective Japanese traditional (Kampo) medicine, hangeshashinto, in an aqueous phase by Matsumoto C1, Sekine-Suzuki E2, Nyui M3, Ueno M3, Nakanishi I3, Omiya Y4, Fukutake M1, Kase Y4, Matsumoto KI5.(PubMed)
(2048) Characterization, antibacterial, antioxidant, and cytotoxic activities of ZnO nanoparticles using Coptidis Rhizoma by Nagajyothi PC1, Sreekanth TV2, Tettey CO1, Jun YI1, Mook SH3.(PubMed)
(2049) Coptisine attenuates obesity-related inflammation through LPS/TLR-4-mediated signaling pathway in Syrian golden hamsters by Zou ZY1, Hu YR1, Ma H1, Wang YZ1, He K1, Xia S1, Wu H2, Xue DF2, Li XG3, Ye XL4.(PubMed)
(2050) [Progress of berberine for treatment of type 2 diabetes]. [Article in Chinese] by Deng XW, Xie N.(PubMed)
(2051) Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations by Tang J1, Feng Y, Tsao S, Wang N, Curtain R, Wang Y.(PubMed)
(2052) Safety evaluation of main alkaloids from Rhizoma Coptidis by Yi J1, Ye X, Wang D, He K, Yang Y, Liu X, Li X.(PubMed)
(2053) Effects of San-Huang-Xie-Xin-tang, a traditional Chinese prescription for clearing away heat and toxin, on the pacemaker activities of interstitial cells of Cajal from the murine small intestine by Kim BJ1, Kim H2, Lee GS3, So I4, Kim SJ5.(PubMed)
(2054) Study of the anti-MRSA activity of Rhizoma coptidis by chemical fingerprinting and broth microdilution methods by Luo JY1, Yan D2, Yang MH3.(PubMed)
(2055) Analgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndrome by Tjong Y1, Ip S, Lao L, Fong HH, Sung JJ, Berman B, Che C.(PubMed)
(2056) Integrated pharmacokinetics of five protoberberine-type alkaloids in normal and insomnic rats after single and multiple oral administration of Jiao-Tai-Wan by He W1, Liu G1, Cai H1, Sun X1, Hou W1, Zhang P2, Xie Z3, Liao Q4.(PubMed)
(2057) Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and AMPK-dependent lipid lowering effect in hepatocytes. Ho FM1, Liao YH, Yang AJ, Lee Chao PD, Hou YC, Huang CT, Lin SR, Lee KR, Huang KC, Lin WW.(PubMed)
(2058) Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats by Gong LL1, Fang LH, Wang SB, Sun JL, Qin HL, Li XX, Wang SB, Du GH.(PubMed)
(2059) Effect of Coptidis Rhizoma extracts in a water-based solution on insulin resistance in 3T3-L1 adipocytes by Yuan Y1, Wang X, Lu X, Marunaka Y, Wang X.(PubMed)
(2060) Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double-blind randomised controlled trial by Li Y1, Kuang H, Shen W, Ma H, Zhang Y, Stener-Victorin E, Hung E, Ng Y, Liu J, Kuang H, Hou L, Wu X.(PubMed)
(2061) Gut microbes and Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice by Xie W1, Gu D, Li J, Cui K, Zhang Y.(PubMed)
(2062) Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin by Wu D1, Wen W, Qi CL, Zhao RX, Lü JH, Zhong CY, Chen YY.(PubMed)
(2063) Jiao tai wan attenuates hepatic lipid accumulation in type 2 diabetes mellitus by Huang Z1, Xu X, Lu F, Wang N, Chen G, Zhao Y, Zou X, Wang K, Dong H, Xu L.(PubMed)
(2064) Traditional chinese medicine in treatment of metabolic syndrome by Yin J1, Zhang H, Ye J. (PubMed)
(2065) Simultaneous determination of ten alkaloids of crude and wine-processed Rhizoma Coptidis aqueous extracts in rat plasma by UHPLC-ESI-MS/MS and its application to a comparative pharmacokinetic study by Qian XC1, Zhang L2, Tao Y3, Huang P1, Li JS4, Chai C3, Li W5, Di LQ1, Cai BC3.(PubMed)
(2066) Effects of San-Huang-Xie-Xin-Tang on U46619-induced increase in pulmonary arterial blood pressure by Tsai HH1, Chen IJ, Lo YC.(PubMed)
(2067) Coptis chinensis alkaloids exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating C/EBP-α and PPAR-γ by Choi JS1, Kim JH2, Ali MY1, Min BS3, Kim GD4, Jung HA5.(PubMed)
(2068) [Pharmacodyamic material basis of rhizoma coptidis on insulin resistance]. [Article in Chinese] by Li J1, Meng X, Fan X, Lai X, Zhang Y, Zeng Y.(PubMed)
(2069) Inhibition of preadipocyte differentiation and lipid accumulation by Orengedokuto treatment of 3T3-L1 cultures. Ikarashi N1, Tajima M, Suzuki K, Toda T, Ito K, Ochiai W, Sugiyama K.(PubMed)
(2070) Potential ex vivo immunomodulatory effects of San-Huang-Xie-Xin-Tang and its component herbs on mice and humans by Li CY1, Hou YC, Lee Chao PD, Shia CS, Hsu IC, Fang SH.(PubMed)
(2071) Lipopolysaccharide increased the acute toxicity of the Rhizoma coptidis extract in mice by increasing the systemic exposure to Rhizoma coptidis alkaloids by Ma BL1, Ma YM, Gao CL, Wu JS, Qiu FR, Wang CH, Wang XH.(PubMed)
The diabetic recipe: Mint sauce with apple and onion
Posted By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Diabetic recipe
Attributed to Delicious Dish for diabetics by Robin Ellis, Published by Skyhorse Publishing Inc. New York. You can view its website atwww.skyhorsepublishing.com.
This to my mind is so much nicer than traditional mint sauce. The apple and onion put a real spring in its step - helped on by the cider vinegar. Goes wonderful with roast lamp or lamp chops.
Leave from a bunch of mint
1 apple - peeled, cored and roughly chopped
1 small onion - quartered
salt
Good splash of cider vinegar
1. Process the mint, apple and onion in a blender - not too finely: it should have texture.
2. Add some salt and a good splash of vinegar. Taste to see if it needs a little more of anything - it may take a couple of goes to get the balance right. Then leave to marinade in the fridge.
3. Bring it back to room temperature before serving.
Weight Loss the Easy Ways
Andrea Albright Featured on Health and Fitness Jan. 2015
will Personally Coach You How to Get There The Easy Way
Monday, 22 June 2015
The Holistic prevention, management and treatment of Polycystic Ovarian Syndrome: TCM Herbal Medicine for Kidney Yin deficiency - Reishi mushroom
By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cancer(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women. Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).
In Traditional Chinese Medicine Perspective
While conventional medicine focus of using synthetic medication to induce ovulation and assisted artificial insemination for infertility couple, if the medicine fail, traditional Chinese medicine views polycystic ovarian syndrome in different approaches. Polycystic ovary syndrome, according to traditional Chinese medicine is a medical condition characterized by accumulative of fluid over a prolonged period of time causes of dampness and phlegms(1247a)(1247b) build up on the ovaries due to the effects of vary differentiations, affecting not only the women’s menstrual cycle, but also ovulation and fertility(1247a)(1247b).
PCOs Treatment according traditional Chinese medicine
Depending to differentiation, most common diagnosis of polycystic ovary syndrome can be classified into
Kidney yin deficiency
Along with common symptoms mentioned above, women with PCOs diagnosed with kidney yin deficiency may also experience yin vacuity induced cold expressive syndrome, including soreness of waist and knees(1848), lassitude(1848) and fatigue(1848), short breath(1848), poor appetite(1848), aversion to cold(184), cold extremities(1848), ringing in the ears(1850), migraine(1849), hearing problems(1850), a dry mouth and throat(1851), pale fingernails(1851), tidal fever(1851)and night sweating(1851), soles(1851) and chest(1851), constipation(1852),,......... as the kidneys no longer perform their functions of regulating fluid in moistening and nourishing organs and tissues of the body. According to TCM, too much cold/raw foods can aggravate the condition.
In the review of the Data base provided by PubMed, kidney yin deficiency may induce functional impairment or metabolic derangements in vital organs/tissues(1853) persuaded a conglomeration of sundry chronic disease state(1853), cognitive dysfunction(1854), vasomotor symptoms(1855),..... leading to accumulation of fluid in the body organ, promoted accentuation of inflammatory development of phlegm.
Kidney yin deficiency has shown to alter amino acid metabolism(1856), energy metabolism(1856) and gut microflora(1856), anovulatory infertility(1857) and
hypertension(1858), hyperinsulinemia(1859) and hyperandrogenia(1859)..... of which related to symptoms of PCOs(1859).
Epidemiological studies suggested that reishi mushroom may be used for prevention and treatment of metabolic syndrome(2022)(2023) and its complications of diabetes(2022)(2024) and cardiovascular disease(2022)(2023)(2024) due its effects on fasting glucose(2028)(2029), insulin sensitve(2029)(2030), lipid abnormality(2031), hypertensive(2032)(2033), anti hyperglycaemic(2010)(2024)(2025), anti hyperlipidemic(2026)(2027), weight control(2034)(2035), obesity(2036).
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(1246) [Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet]. [Article in Chinese] by Feng Y, Gao YP.(PubMed)
(1247) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan, J.(PubMed)
(1247a) A Comprehensive Treatment of Polycystic Ovarian Syndrome (PCOS) by Liqin Zhao(1848) ontrolled trail on moxibustion for maintenance hemodialysis patients in deficiency syndrome]. [Article in Chinese] Li N1, Qiu MY, Hao JR, Zhang QM, Wang SH, Liang F, Yin Y, Luan J, Ge GZ, Qin T, Li BQ.(PubMed)
(1848) ontrolled trail on moxibustion for maintenance hemodialysis patients in deficiency syndrome]. [Article in Chinese] Li N1, Qiu MY, Hao JR, Zhang QM, Wang SH, Liang F, Yin Y, Luan J, Ge GZ, Qin T, Li BQ.(PubMed)
(1849) [Observation on therapeutic effect of the new Bianshi (stone needle) therapy on migraine]. [Article in Chinese] Yin ZJ1, Yan YJ, Bao HL(PubMed)
(1850) [Study on relation of kidney-deficiency with hearing damage and serum trace elements in patients with chronic nephropathy]. [Article in Chinese] by Yu J1, Xu Y, Fu XD.(PubMed)
(1851) [A family survey of syndromes of traditional Chinese medicine in patients with beta-thalassemia]. [Article in Chinese] by Wang WJ1, Wu ZK, Zhang XH, Liu WJ, Liu YM, Fang SP, Wang RX, Zhang C, Li PP, Luo RG.(PubMed)
(1852) The clinical experiences of Dr. CAI Gan in treating chronic constipation by Zhang ZL1, Zhu MP, Liu Q, Lei YX.(PubMed)
(1853) [Analysis of 35 cases of pathology in yin deficiency syndrome]. [Article in Chinese] by Dai HL, Chen ZL, Song QL.(PubMed)
(1854) Liuwei Dihuang decoction facilitates the induction of long-term potentiation (LTP) in senescence accelerated mouse/prone 8 (SAMP8) hippocampal slices by inhibiting voltage-dependent calcium channels (VDCCs) and promoting N-methyl-d-aspartate receptor (NMDA) receptors by Huang Y1, Zhang H, Yang S, Qiao H, Zhou W, Zhang Y.(PubMed)
(1855) Diagnosis of symptomatic postmenopausal women by traditional Chinese medicine practitioners by Zell B1, Hirata J, Marcus A, Ettinger B, Pressman A, Ettinger KM.(PubMed)
(1856) An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China by Jiang N1, Liu HF2, Li SD1, Zhou WX1, Zhang YX1, Zhang Q3, Yan XZ3.(PubMed)
(1857) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan J.(PubMed)
(1858) Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients by Wang J1, Xiong X1, Liu W1.(PubMed)
(1859) [Clinical observation on treatment of hyperinsulinemia and hyperandrogenism anovulatory patient with replenishing kidney-yin drugs]. [Article in Chinese] by Zhou LR1, Yu J.(PubMed)
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cancer(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women. Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).
In Traditional Chinese Medicine Perspective
While conventional medicine focus of using synthetic medication to induce ovulation and assisted artificial insemination for infertility couple, if the medicine fail, traditional Chinese medicine views polycystic ovarian syndrome in different approaches. Polycystic ovary syndrome, according to traditional Chinese medicine is a medical condition characterized by accumulative of fluid over a prolonged period of time causes of dampness and phlegms(1247a)(1247b) build up on the ovaries due to the effects of vary differentiations, affecting not only the women’s menstrual cycle, but also ovulation and fertility(1247a)(1247b).
PCOs Treatment according traditional Chinese medicine
Depending to differentiation, most common diagnosis of polycystic ovary syndrome can be classified into
Kidney yin deficiency
Along with common symptoms mentioned above, women with PCOs diagnosed with kidney yin deficiency may also experience yin vacuity induced cold expressive syndrome, including soreness of waist and knees(1848), lassitude(1848) and fatigue(1848), short breath(1848), poor appetite(1848), aversion to cold(184), cold extremities(1848), ringing in the ears(1850), migraine(1849), hearing problems(1850), a dry mouth and throat(1851), pale fingernails(1851), tidal fever(1851)and night sweating(1851), soles(1851) and chest(1851), constipation(1852),,......... as the kidneys no longer perform their functions of regulating fluid in moistening and nourishing organs and tissues of the body. According to TCM, too much cold/raw foods can aggravate the condition.
In the review of the Data base provided by PubMed, kidney yin deficiency may induce functional impairment or metabolic derangements in vital organs/tissues(1853) persuaded a conglomeration of sundry chronic disease state(1853), cognitive dysfunction(1854), vasomotor symptoms(1855),..... leading to accumulation of fluid in the body organ, promoted accentuation of inflammatory development of phlegm.
Kidney yin deficiency has shown to alter amino acid metabolism(1856), energy metabolism(1856) and gut microflora(1856), anovulatory infertility(1857) and
hypertension(1858), hyperinsulinemia(1859) and hyperandrogenia(1859)..... of which related to symptoms of PCOs(1859).
5. Reishi mushroom
Reishi mushroom or Lingzhi is a fungal species in the genus Ganoderma, belongings to the family Ganodermataceae, native to Asia. The herb has been use in traditional medicine as anti-cancers(2004)uro protective(2005)(2006) and anti inflammatory(2007)(2008), antioxidant(2010)(2013)(2011), neuro protective(2009)(2012) agent and to enhance immune function(2014)(2015), treat liver injury(2016)(2018) and diseases(2017)(2018), protect against neuron degeneration(2019)(2020),..... by enhancing the functions of Lung, Kidney, Liver, Heart, Spleen, Stomach. channels(2021).
Reishi mushroom or Lingzhi is a fungal species in the genus Ganoderma, belongings to the family Ganodermataceae, native to Asia. The herb has been use in traditional medicine as anti-cancers(2004)uro protective(2005)(2006) and anti inflammatory(2007)(2008), antioxidant(2010)(2013)(2011), neuro protective(2009)(2012) agent and to enhance immune function(2014)(2015), treat liver injury(2016)(2018) and diseases(2017)(2018), protect against neuron degeneration(2019)(2020),..... by enhancing the functions of Lung, Kidney, Liver, Heart, Spleen, Stomach. channels(2021).
Chemical constituents(2021)
1. Ganodermic acid G
2. Lucidone A
3. Fungal lysozyme
4. Pachymic acid C
5. Stellasterol
6. Polyporenic acid
7. Pterocarpin
8. Trifolirhizin
9. Kuraridin
10. Kuraridinol
11. Oxalic acid
12. Etc.
Epidemiological studies suggested that reishi mushroom may be used for prevention and treatment of metabolic syndrome(2022)(2023) and its complications of diabetes(2022)(2024) and cardiovascular disease(2022)(2023)(2024) due its effects on fasting glucose(2028)(2029), insulin sensitve(2029)(2030), lipid abnormality(2031), hypertensive(2032)(2033), anti hyperglycaemic(2010)(2024)(2025), anti hyperlipidemic(2026)(2027), weight control(2034)(2035), obesity(2036).
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(1246) [Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet]. [Article in Chinese] by Feng Y, Gao YP.(PubMed)
(1247) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan, J.(PubMed)
(1247a) A Comprehensive Treatment of Polycystic Ovarian Syndrome (PCOS) by Liqin Zhao(1848) ontrolled trail on moxibustion for maintenance hemodialysis patients in deficiency syndrome]. [Article in Chinese] Li N1, Qiu MY, Hao JR, Zhang QM, Wang SH, Liang F, Yin Y, Luan J, Ge GZ, Qin T, Li BQ.(PubMed)
(1849) [Observation on therapeutic effect of the new Bianshi (stone needle) therapy on migraine]. [Article in Chinese] Yin ZJ1, Yan YJ, Bao HL(PubMed)
(1850) [Study on relation of kidney-deficiency with hearing damage and serum trace elements in patients with chronic nephropathy]. [Article in Chinese] by Yu J1, Xu Y, Fu XD.(PubMed)
(1851) [A family survey of syndromes of traditional Chinese medicine in patients with beta-thalassemia]. [Article in Chinese] by Wang WJ1, Wu ZK, Zhang XH, Liu WJ, Liu YM, Fang SP, Wang RX, Zhang C, Li PP, Luo RG.(PubMed)
(1852) The clinical experiences of Dr. CAI Gan in treating chronic constipation by Zhang ZL1, Zhu MP, Liu Q, Lei YX.(PubMed)
(1853) [Analysis of 35 cases of pathology in yin deficiency syndrome]. [Article in Chinese] by Dai HL, Chen ZL, Song QL.(PubMed)
(1854) Liuwei Dihuang decoction facilitates the induction of long-term potentiation (LTP) in senescence accelerated mouse/prone 8 (SAMP8) hippocampal slices by inhibiting voltage-dependent calcium channels (VDCCs) and promoting N-methyl-d-aspartate receptor (NMDA) receptors by Huang Y1, Zhang H, Yang S, Qiao H, Zhou W, Zhang Y.(PubMed)
(1855) Diagnosis of symptomatic postmenopausal women by traditional Chinese medicine practitioners by Zell B1, Hirata J, Marcus A, Ettinger B, Pressman A, Ettinger KM.(PubMed)
(1856) An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China by Jiang N1, Liu HF2, Li SD1, Zhou WX1, Zhang YX1, Zhang Q3, Yan XZ3.(PubMed)
(1857) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan J.(PubMed)
(1858) Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients by Wang J1, Xiong X1, Liu W1.(PubMed)
(1859) [Clinical observation on treatment of hyperinsulinemia and hyperandrogenism anovulatory patient with replenishing kidney-yin drugs]. [Article in Chinese] by Zhou LR1, Yu J.(PubMed)
(2004) Ganoderma lucidum (Reishi mushroom) for cancer treatment by Jin X1, Ruiz Beguerie J, Sze DM, Chan GC.(PubMed)
(2005) Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43 by Dai S1, Liu J, Sun X, Wang N.(PubMed)
(2006) Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3 by Hsieh TC1, Wu JM.(PubMed)
(2007) Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models by Suarez-Arroyo IJ1, Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J, Schneider RJ, Martínez-Montemayor MM.(PubMed)
(2008) Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer by Martínez-Montemayor MM1, Acevedo RR, Otero-Franqui E, Cubano LA, Dharmawardhane SF.(PubMed)
(2009) Neurometabolic Effect of Altaian Fungus Ganoderma lucidum (Reishi Mushroom) in Rats Under Moderate Alcohol Consumption by Shevelev OB1, Akulov AE1, Dotsenko AS2, Kontsevaya GV1, Zolotykh MA2, Gerlinskaya LA1, Veprev SG1, Goryachkovskaya TN1, Zhukova NA3, Kolchanov NA1,3, Pel'tek SE1, Moshkin MP1,2,4(PubMed)
(2010) Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism by Pan D1, Zhang D, Wu J, Chen C, Xu Z, Yang H, Zhou P.(PubMed)
(2011) Structural characterization and antioxidative activity of low-molecular-weights beta-1,3-glucan from the residue of extracted Ganoderma lucidum fruiting bodies by Kao PF1, Wang SH, Hung WT, Liao YH, Lin CM, Yang WB.(PubMed)
(2012) Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus by Zhou Y1, Qu ZQ, Zeng YS, Lin YK, Li Y, Chung P, Wong R, Hägg U.(PubMed)
(2013) Determination of the antioxidant activity and polyphenol contents of wild Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W.Curt. Fr.) P. Karst. (higher Basidiomycetes) from central Himalayan hills of India by Mohsin M1, Negi P, Ahmed Z.(PubMed)
(2014) Immuno-modulatory activity of Ganoderma lucidum-derived polysacharide on human monocytoid dendritic cells pulsed with Der p 1 allergen by Jan RH1, Lin TY, Hsu YC, Lee SS, Lo SY, Chang M, Chen LK, Lin YL.(PubMed)
(2015) Optimization extraction of Ganoderma lucidum polysaccharides and its immunity and antioxidant activities. Pan K1, Jiang Q, Liu G, Miao X, Zhong D.(PubMed)
(2016) In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury by Yang XJ1, Liu J, Ye LB, Yang F, Ye L, Gao JR, Wu ZH.(PubMed)
(2017) Hepatoprotective effects of mushrooms by Soares AA1, de Sá-Nakanishi AB, Bracht A, da Costa SM, Koehnlein EA, de Souza CG, Peralta RM.(PubMed)
(2018) Hepatoprotective effects of aqueous extract from Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher basidiomycetes) on α-amanitin-induced liver injury in mice by Wu X1, Zeng J, Hu J, Liao Q, Zhou R, Zhang P, Chen Z.(PübMed)
(2019) Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum by Lai CS1, Yu MS, Yuen WH, So KF, Zee SY, Chang RC.(PubMed)
(2020) Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicit by Yu MS1, Leung SK, Lai SW, Che CM, Zee SY, So KF, Yuen WH, Chang RC.(PubMed)
(2021) Ling zhi(Complementary and Alternative Healing University)
(2022) Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum by Grienke U1, Mihály-Bison J, Schuster D, Afonyushkin T, Binder M, Guan SH, Cheng CR, Wolber G, Stuppner H, Guo DA, Bochkov VN, Rollinger JM.(PubMed)
(2023) Effect of Ganoderma lucidum extract on adipocyte differentiation and adiponectin gene expression in the murine pre-adipocyte cell line, 3T3-L1. by Shimojo Y1, Kosaka K, Shirasawa T.(PubMed)
(2024) Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors by Klupp NL1, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A.(PubMed)
(2025) Antihyperglycemic effect of ganoderma lucidum polysaccharides on streptozotocin-induced diabetic mice by Li F1, Zhang Y, Zhong Z.(PubMed)
(2026) Isolation and structure determination of a cholesterol esterase inhibitor from Ganoderma lucidum by Kim SD1.(PubMed)
(2027) Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors by Hajjaj H1, Macé C, Roberts M, Niederberger P, Fay LB.(PubMed)
(2027) Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors by Hajjaj H1, Macé C, Roberts M, Niederberger P, Fay LB.(PubMed)
(2028) Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice by Xiao C1, Wu QP, Cai W, Tan JB, Yang XB, Zhang JM.(PubMed)
(2029) Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin by Lv L1, Wu SY, Wang GF, Zhang JJ, Pang JX, Liu ZQ, Xu W, Wu SG, Rao JJ.(PubMed)
(2030) Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin by Wu SY1, Wang GF, Liu ZQ, Rao JJ, Lü L, Xu W, Wu SG, Zhang JJ.(PubMed)
(2031) Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators by Futrakul N1, Boonyen M, Patumraj S, Siriviriyakul P, Tosukhowong P, Futrakul P.(PubMed)
(2032) Wound healing activity of an aqueous extract of the Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes) by Gupta A1, Kirar V1, Keshri GK1, Gola S1, Yadav A1, Negi PS2, Misra K3.(PubMed)
(2033) Anti-angiotensin converting enzyme (ACE) proteins from mycelia of Ganoderma lucidum (Curtis) by P. Karst. Mohamad Ansor N1, Abdullah N, Aminudin N.(PubMed)
(2034) Development of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (Higher Basidiomycetes) polysaccharides injection formulation by Jiang Y1, He A2, Liu Y3, Xie B1, Li Y4, Deng Y5, Liu X5, Liu Q6.(PubMed)
(2035) Changes in weight gain, faecal oocyst count and packed cell volume of Eimeria tenella-infected broilers treated with a wild mushroom (Ganoderma lucidum) aqueous extract by Ogbe AO1, Atawodi SE, Abdu PA, Sannusi A, Itodo AE.(PubMed)
(2036) [Role of phytotherapy in the prevention and treatment of obesity]. [Article in Hungarian] by Balázs A1.(PubMed)
The diabetic recipe: A simple sauce
Posted By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Diabetic recipe
Attributed to Delicious Dish for diabetics by Robin Ellis, Published by Skyhorse Publishing Inc. New York. You can view its website atwww.skyhorsepublishing.com.
Serve 4
For white fish - grilled or roasted. You would try adding some finely chopped mint leaves and a little very finely sliced garlic.
4 tbsp./ 80ml/3 fl or olive oil
juice of a lemon
salt and pepper
Whisk all the ingredients together
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Diabetic recipe
Attributed to Delicious Dish for diabetics by Robin Ellis, Published by Skyhorse Publishing Inc. New York. You can view its website atwww.skyhorsepublishing.com.
Serve 4
For white fish - grilled or roasted. You would try adding some finely chopped mint leaves and a little very finely sliced garlic.
4 tbsp./ 80ml/3 fl or olive oil
juice of a lemon
salt and pepper
Whisk all the ingredients together
Sunday, 21 June 2015
The Holistic prevention, management and treatment of Polycystic Ovarian Syndrome: TCM Herbal Medicine for Kidney Yin deficiency - Xi yang shen
By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cancer(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women. Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).
Traditional Chinese Perspective In Management and Treatment of PCOs
While conventional medicine focus of using synthetic medication to induce ovulation and assisted artificial insemination for infertility couple, if the medicine fail, traditional Chinese medicine views polycystic ovarian syndrome in different approaches. Polycystic ovary syndrome, according to traditional Chinese medicine is a medical condition characterized by accumulative of fluid over a prolonged period of time causes of dampness and phlegms(1247a)(1247b) build up on the ovaries due to the effects of vary differentiations, affecting not only the women’s menstrual cycle, but also ovulation and fertility(1247a)(1247b).
PCOs Treatment according traditional Chinese medicine
Depending to differentiation, most common diagnosis of polycystic ovary syndrome can be classified into
Kidney yin deficiency
Along with common symptoms mentioned above, women with PCOs diagnosed with kidney yin deficiency may also experience yin vacuity induced cold expressive syndrome, including soreness of waist and knees(1848), lassitude(1848) and fatigue(1848), short breath(1848), poor appetite(1848), aversion to cold(184), cold extremities(1848), ringing in the ears(1850), migraine(1849), hearing problems(1850), a dry mouth and throat(1851), pale fingernails(1851), tidal fever(1851)and night sweating(1851), soles(1851) and chest(1851), constipation(1852),,......... as the kidneys no longer perform their functions of regulating fluid in moistening and nourishing organs and tissues of the body. According to TCM, too much cold/raw foods can aggravate the condition.
In the review of the Data base provided by PubMed, kidney yin deficiency may induce functional impairment or metabolic derangements in vital organs/tissues(1853) persuaded a conglomeration of sundry chronic disease state(1853), cognitive dysfunction(1854), vasomotor symptoms(1855),..... leading to accumulation of fluid in the body organ, promoted accentuation of inflammatory development of phlegm.
Kidney yin deficiency has shown to alter amino acid metabolism(1856), energy metabolism(1856) and gut microflora(1856), anovulatory infertility(1857) and
hypertension(1858), hyperinsulinemia(1859) and hyperandrogenia(1859)..... of which related to symptoms of PCOs(1859).
4. Xi yang shen(Panax quinquefolium L., American ginseng)
North America Ginseng is also known as P. quinquefolius American ginseng (root), is considered as yin promoting, as the roots is growth from a hot area, according to traditional Chinese medicine(1972). Ginseng North America has been used in TCM as anti cancers(1974)(1975)(1976), anti psychotic(1977)(1979), anti inflammatory(1980)(1981) and antioxidant(1979)(1982), immumomodulatory(1983)(1984), CNS protective(1979)(1978)(1981), wound healing(1979) advocate and to relive pain(1991)(1992) and treat sexual dysfunction(1985)(1986), quench thirst(1973), heal deficiency of lungs(1973)and chronic asthma(1987) and to treat fatigue(1988)(1989), chronic fever(1990),... by enhancing heart, lung and kidney channels(1973).
Chemical constituents(1973)
1. Octanol
2. Hexanoic acid
3. Pindecane
4. Pinocarveol
5. Octanoic acid
7. Dodecane
8. 3-phenylhexane
9. 1-phenylhexane
10. Pulegone
11. Beta-farnesene
12. Alpha-curcumene,
13. Alpha-cedrene
14. Beta-bisabolene
15. Beta-caryophyllene
16. Caproic acid
17. Heptanoic acid
18. Caprylic acid
19. Nonanoic acid
20. Palmitic acid
21. stearic acid
22. octadecenoic acid
23. Linoleic acid
24. Etc.
Xi yang shen containing a similar ingredients of panax gingseng with opposite cool and warm in nature has found no different for prevention and treatment of metabolic syndrome in pharmaceutical single or combined ingredient withdrawal(1994)(1995), The whole herb has exhibited positive effects on islet protection(1994) insulin sensitve(1994)(1995)(1996), hypertensive(1993)(1996), anti hyperglycaemic(1993)(1994), anti hyperlipidemic(1993)(1996), , obesity(1993)(1994), through its carbohydrate(2001)(2003) and lipid metabolism(2002)(2003).......induced complications of diabetes(1999)(2000) and cardiovascular disease(1997)(1998)(1981) through enhancement of stroke volume, ejection fraction, cardiac output, and left ventricle pressure(2003).
Xi yang shen containing a similar ingredients of panax gingseng with opposite cool and warm in nature has found no different for prevention and treatment of metabolic syndrome in pharmaceutical single or combined ingredient withdrawal(1994)(1995), The whole herb has exhibited positive effects on islet protection(1994) insulin sensitve(1994)(1995)(1996), hypertensive(1993)(1996), anti hyperglycaemic(1993)(1994), anti hyperlipidemic(1993)(1996), , obesity(1993)(1994), through its carbohydrate(2001)(2003) and lipid metabolism(2002)(2003).......induced complications of diabetes(1999)(2000) and cardiovascular disease(1997)(1998)(1981) through enhancement of stroke volume, ejection fraction, cardiac output, and left ventricle pressure(2003).
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(1246) [Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet]. [Article in Chinese] by Feng Y, Gao YP.(PubMed)
(1247) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan, J.(PubMed)
(1247a) A Comprehensive Treatment of Polycystic Ovarian Syndrome (PCOS) by Liqin Zhao(1848) ontrolled trail on moxibustion for maintenance hemodialysis patients in deficiency syndrome]. [Article in Chinese] Li N1, Qiu MY, Hao JR, Zhang QM, Wang SH, Liang F, Yin Y, Luan J, Ge GZ, Qin T, Li BQ.(PubMed)
(1848) ontrolled trail on moxibustion for maintenance hemodialysis patients in deficiency syndrome]. [Article in Chinese] Li N1, Qiu MY, Hao JR, Zhang QM, Wang SH, Liang F, Yin Y, Luan J, Ge GZ, Qin T, Li BQ.(PubMed)
(1849) [Observation on therapeutic effect of the new Bianshi (stone needle) therapy on migraine]. [Article in Chinese] Yin ZJ1, Yan YJ, Bao HL(PubMed)
(1850) [Study on relation of kidney-deficiency with hearing damage and serum trace elements in patients with chronic nephropathy]. [Article in Chinese] by Yu J1, Xu Y, Fu XD.(PubMed)
(1851) [A family survey of syndromes of traditional Chinese medicine in patients with beta-thalassemia]. [Article in Chinese] by Wang WJ1, Wu ZK, Zhang XH, Liu WJ, Liu YM, Fang SP, Wang RX, Zhang C, Li PP, Luo RG.(PubMed)
(1852) The clinical experiences of Dr. CAI Gan in treating chronic constipation by Zhang ZL1, Zhu MP, Liu Q, Lei YX.(PubMed)
(1853) [Analysis of 35 cases of pathology in yin deficiency syndrome]. [Article in Chinese] by Dai HL, Chen ZL, Song QL.(PubMed)
(1854) Liuwei Dihuang decoction facilitates the induction of long-term potentiation (LTP) in senescence accelerated mouse/prone 8 (SAMP8) hippocampal slices by inhibiting voltage-dependent calcium channels (VDCCs) and promoting N-methyl-d-aspartate receptor (NMDA) receptors by Huang Y1, Zhang H, Yang S, Qiao H, Zhou W, Zhang Y.(PubMed)
(1855) Diagnosis of symptomatic postmenopausal women by traditional Chinese medicine practitioners by Zell B1, Hirata J, Marcus A, Ettinger B, Pressman A, Ettinger KM.(PubMed)
(1856) An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China by Jiang N1, Liu HF2, Li SD1, Zhou WX1, Zhang YX1, Zhang Q3, Yan XZ3.(PubMed)
(1857) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan J.(PubMed)
(1858) Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients by Wang J1, Xiong X1, Liu W1.(PubMed)
(1859) [Clinical observation on treatment of hyperinsulinemia and hyperandrogenism anovulatory patient with replenishing kidney-yin drugs]. [Article in Chinese] by Zhou LR1, Yu J.(PubMed)
(1972) Popular #Herbs - #Ginseng, Asian (Panax ginseng) and Ginseng, North America by Kyle J. Norton
(1973) Xi yang shen(Complementary and Alternative Healing University)
(1974) American Ginseng inhibits induced COX-2 and NFKB activation in breast cancer cells by Peralta EA1, Murphy LL, Minnis J, Louis S, Dunnington GL.(PubMed)
(1975) Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation by King ML1, Adler SR, Murphy LL.(PubMed)
(1976) Sensitization of a tumor, but not normal tissue, to the cytotoxic effect of ionizing radiation using Panax notoginseng extract by Chen FD1, Wu MC, Wang HE, Hwang JJ, Hong CY, Huang YT, Yen SH, Ou YH.(PubMed)
(1977) Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice by Chatterjee M1, Singh S, Kumari R, Verma AK, Palit G.(PubMed)
(1978) Non-ginsenoside nicotinic activity in ginseng species. Lewis R1, Wake G, Court G, Court JA, Pickering AT, Kim YC, Perry EK.(PubMed)
(1979) Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium by Chen CF1, Chiou WF, Zhang JT.(PubMed)
(1980) Cytoprotective effect of American ginseng in a rat ethanol gastric ulcer model by Huang CC1, Chen YM1, Wang DC1, Chiu CC1, Lin WT1, Huang CY1, Hsu MC2.(PubMed)
(1981) Evaluation of antibacterial and anti-inflammatory activities of less polar ginsenosides produced from polar ginsenosides by heat-transformation by Wang L1, Yang X, Yu X, Yao Y, Ren G.(PubMed)
(1982) Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius by Lee LS1, Wise SD, Chan C, Parsons TL, Flexner C, Lietman PS.(PubMed)
(1983) Neoplasm prevention and immuno-enhancement mediated by daily consumption of a proprietary extract from North American ginseng by elderly mice of a cancer-prone strain by Durairaj P1, Miller SC.(PubMed)
(1984) Dietary supplementation with an extract of North American ginseng in adult and juvenile mice increases natural killer cells by Miller SC1, Ti L, Shan J.(PubMed)
(1985) Ginseng, sex behavior, and nitric oxide by Murphy LL1, Lee TJ.(PubMed)
(1986) Ginsenosides-induced nitric oxide-mediated relaxation of the rabbit corpus cavernosum by Chen X1, Lee TJ.(PubMed)
(1987) Compound CVT-E002 attenuates allergen-induced airway inflammation and airway hyperresponsiveness, in vivo by Ebeling C1, Wu Y, Skappak C, Gordon JR, Ilarraza R, Adamko DJ.(PubMed)
(1988) Anti-fatigue effects of proteins isolated from Panax quinquefolium by Qi B1, Liu L1, Zhang H1, Zhou GX1, Wang S1, Duan XZ1, Bai XY1, Wang SM1, Zhao DQ2.(PubMed)
(1989) American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study by Kim E1, Cameron M, Lovera J, Schaben L, Bourdette D, Whitham R.(PubMed)
(1990) Ginseng By Marian Kim, page 2-3
(1991) The role of spinal adrenergic receptors on the antinociception of ginsenosides in a rat postoperative pain model by Kim IJ1, Park CH, Lee SH, Yoon MH.(PubMed)
(1992) Additive interaction of intrathecal ginsenosides and neostigmine in the rat formalin test by Park CH1, Kim PN, Lee SH, Yoon MH.(PubMed)
(1993) Targeting metabolic syndrome: candidate natural agents. Xia X1, Weng J.(PubMed)
(1994) Traditional chinese medicine in treatment of metabolic syndrome by Yin J1, Zhang H, Ye J.(PubMed)
(1995) Vinegar-processed ginseng radix improves metabolic syndrome induced by a high fat diet in ICR mice by Yun SN1, Ko SK, Lee KH, Chung SH.(PubMed)
(1996) Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus by Vuksan V1, Sievenpiper JL, Xu Z, Wong EY, Jenkins AL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Stavro MP.(PubMed)
(1997) American ginseng acutely regulates contractile function of rat heart by Jiang M1, Murias JM2, Chrones T3, Sims SM3, Lui E4, Noble EG1.(PubMed)
(1998) Shenyuan, an extract of American Ginseng and Corydalis Tuber formula, attenuates cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and oxidative stress in a porcine model of acute myocardial infarction by Zhu XY1, Zhang ZL, Li P, Liang WY, Feng XR, Liu ML.(PubMed)
(1999) American Ginseng Extract (Panax quinquefolius L.) Is Safe in Long-Term Use in Type 2 Diabetic Patients. Mucalo I1, Jovanovski E2, Vuksan V3, Božikov V4, Romić Z5, Rahelić D4.(PubMed)
(2000) Effect of American ginseng (Panax quinquefolius L.) on glycemic control in type 2 diabetes by Mucalo I1, Rahelić D, Jovanovski E, Bozikov V, Romić Z, Vuksan V.(PubMed)
(2001) American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus by Vuksan V1, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Xu Z, Vidgen E.(PubMed)
(2002) Panax quinquefolium saponins protects low density lipoproteins from oxidation by Li J1, Huang M, Teoh H, Man RY.(PubMed)
(2003) Preventive effects of North American Ginseng (Panax quinquefolius) on Diabetic Retinopathy and Cardiomyopathy, vy Subhrojit Sen,1,3 Shali Chen,1 Yuexiu Wu,1 Biao Feng,1 Edmund K Lui2,3 and Subrata Chakrabarti1,3*(PHYTOTHERAPY RESEARCH)
(1974) American Ginseng inhibits induced COX-2 and NFKB activation in breast cancer cells by Peralta EA1, Murphy LL, Minnis J, Louis S, Dunnington GL.(PubMed)
(1975) Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation by King ML1, Adler SR, Murphy LL.(PubMed)
(1976) Sensitization of a tumor, but not normal tissue, to the cytotoxic effect of ionizing radiation using Panax notoginseng extract by Chen FD1, Wu MC, Wang HE, Hwang JJ, Hong CY, Huang YT, Yen SH, Ou YH.(PubMed)
(1977) Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice by Chatterjee M1, Singh S, Kumari R, Verma AK, Palit G.(PubMed)
(1978) Non-ginsenoside nicotinic activity in ginseng species. Lewis R1, Wake G, Court G, Court JA, Pickering AT, Kim YC, Perry EK.(PubMed)
(1979) Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium by Chen CF1, Chiou WF, Zhang JT.(PubMed)
(1980) Cytoprotective effect of American ginseng in a rat ethanol gastric ulcer model by Huang CC1, Chen YM1, Wang DC1, Chiu CC1, Lin WT1, Huang CY1, Hsu MC2.(PubMed)
(1981) Evaluation of antibacterial and anti-inflammatory activities of less polar ginsenosides produced from polar ginsenosides by heat-transformation by Wang L1, Yang X, Yu X, Yao Y, Ren G.(PubMed)
(1982) Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius by Lee LS1, Wise SD, Chan C, Parsons TL, Flexner C, Lietman PS.(PubMed)
(1983) Neoplasm prevention and immuno-enhancement mediated by daily consumption of a proprietary extract from North American ginseng by elderly mice of a cancer-prone strain by Durairaj P1, Miller SC.(PubMed)
(1984) Dietary supplementation with an extract of North American ginseng in adult and juvenile mice increases natural killer cells by Miller SC1, Ti L, Shan J.(PubMed)
(1985) Ginseng, sex behavior, and nitric oxide by Murphy LL1, Lee TJ.(PubMed)
(1986) Ginsenosides-induced nitric oxide-mediated relaxation of the rabbit corpus cavernosum by Chen X1, Lee TJ.(PubMed)
(1987) Compound CVT-E002 attenuates allergen-induced airway inflammation and airway hyperresponsiveness, in vivo by Ebeling C1, Wu Y, Skappak C, Gordon JR, Ilarraza R, Adamko DJ.(PubMed)
(1988) Anti-fatigue effects of proteins isolated from Panax quinquefolium by Qi B1, Liu L1, Zhang H1, Zhou GX1, Wang S1, Duan XZ1, Bai XY1, Wang SM1, Zhao DQ2.(PubMed)
(1989) American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study by Kim E1, Cameron M, Lovera J, Schaben L, Bourdette D, Whitham R.(PubMed)
(1990) Ginseng By Marian Kim, page 2-3
(1991) The role of spinal adrenergic receptors on the antinociception of ginsenosides in a rat postoperative pain model by Kim IJ1, Park CH, Lee SH, Yoon MH.(PubMed)
(1992) Additive interaction of intrathecal ginsenosides and neostigmine in the rat formalin test by Park CH1, Kim PN, Lee SH, Yoon MH.(PubMed)
(1993) Targeting metabolic syndrome: candidate natural agents. Xia X1, Weng J.(PubMed)
(1994) Traditional chinese medicine in treatment of metabolic syndrome by Yin J1, Zhang H, Ye J.(PubMed)
(1995) Vinegar-processed ginseng radix improves metabolic syndrome induced by a high fat diet in ICR mice by Yun SN1, Ko SK, Lee KH, Chung SH.(PubMed)
(1996) Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus by Vuksan V1, Sievenpiper JL, Xu Z, Wong EY, Jenkins AL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Stavro MP.(PubMed)
(1997) American ginseng acutely regulates contractile function of rat heart by Jiang M1, Murias JM2, Chrones T3, Sims SM3, Lui E4, Noble EG1.(PubMed)
(1998) Shenyuan, an extract of American Ginseng and Corydalis Tuber formula, attenuates cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and oxidative stress in a porcine model of acute myocardial infarction by Zhu XY1, Zhang ZL, Li P, Liang WY, Feng XR, Liu ML.(PubMed)
(1999) American Ginseng Extract (Panax quinquefolius L.) Is Safe in Long-Term Use in Type 2 Diabetic Patients. Mucalo I1, Jovanovski E2, Vuksan V3, Božikov V4, Romić Z5, Rahelić D4.(PubMed)
(2000) Effect of American ginseng (Panax quinquefolius L.) on glycemic control in type 2 diabetes by Mucalo I1, Rahelić D, Jovanovski E, Bozikov V, Romić Z, Vuksan V.(PubMed)
(2001) American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus by Vuksan V1, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Xu Z, Vidgen E.(PubMed)
(2002) Panax quinquefolium saponins protects low density lipoproteins from oxidation by Li J1, Huang M, Teoh H, Man RY.(PubMed)
(2003) Preventive effects of North American Ginseng (Panax quinquefolius) on Diabetic Retinopathy and Cardiomyopathy, vy Subhrojit Sen,1,3 Shali Chen,1 Yuexiu Wu,1 Biao Feng,1 Edmund K Lui2,3 and Subrata Chakrabarti1,3*(PHYTOTHERAPY RESEARCH)
The diabetic recipe: Green sauce
Posted By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Diabetic recipe
Attributed to Delicious Dish for diabetics by Robin Ellis, Published by Skyhorse Publishing Inc. New York. You can view its website atwww.skyhorsepublishing.com.
This is a stunner and goes well with salmon fillet or chicken. You need a decent pile of herbs. Use whatever is available with parley, mint and chives as the base.
1 bunch parley
1 bunch mint
2 bunch chives
1 bunch chervil/tarragon
1 tbsp. capers
salt and pepper
2 cloves of garlic - sliced wafer-thin
1 tbsp. Dijon
2 lemon - juiced
200 ml/7fl oz./3/4 cup olive oil
1. Pile the herbs together and chop them roughly.
2. Add the capers, salt and garlic to the pile and chop thoroughly.
3. Put this in a bowl and mix in the mustard, lemon juice and the oil. Seasoning with pepper.
4. Taste it for the balance of lemon and olive oil: you should end up with a rough mush, a delicious looking green mess.
Weight Loss the Easy Ways
Andrea Albright Featured on Health and Fitness Jan. 2015
will Personally Coach You How to Get There The Easy Way
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Diabetic recipe
Attributed to Delicious Dish for diabetics by Robin Ellis, Published by Skyhorse Publishing Inc. New York. You can view its website atwww.skyhorsepublishing.com.
This is a stunner and goes well with salmon fillet or chicken. You need a decent pile of herbs. Use whatever is available with parley, mint and chives as the base.
1 bunch parley
1 bunch mint
2 bunch chives
1 bunch chervil/tarragon
1 tbsp. capers
salt and pepper
2 cloves of garlic - sliced wafer-thin
1 tbsp. Dijon
2 lemon - juiced
200 ml/7fl oz./3/4 cup olive oil
1. Pile the herbs together and chop them roughly.
2. Add the capers, salt and garlic to the pile and chop thoroughly.
3. Put this in a bowl and mix in the mustard, lemon juice and the oil. Seasoning with pepper.
4. Taste it for the balance of lemon and olive oil: you should end up with a rough mush, a delicious looking green mess.
Weight Loss the Easy Ways
Andrea Albright Featured on Health and Fitness Jan. 2015
will Personally Coach You How to Get There The Easy Way
Subscribe to:
Posts (Atom)